The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...

So, which respiratory virus invaded your cells? Several types of viruses could be the culprit: respiratory syncytial virus ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

(HealthDay News) — Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

Dr. April Miller with Mississippi Public Health Institute lists some RSV symptoms to look for. “The symptoms are typically ...

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.

Flu cases are surging across the commonwealth but for the youngest Pennsylvanians, another potentially dangerous respiratory ...

Human Metapneumovirus (HMPV) is a common but often underrecognised respiratory virus that primarily affects the respiratory tract.

COVID-19 activity is increasing in most regions, with test positivity rising to 7.1%. Emergency department visits are also on the rise from previously low levels. The CDC anticipates continued ...